ArticleFrontiers in oncology2021

The Effectiveness and Safety of Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer Patients With Stage III/IV: A Multicenter Study.

Jason C Hsu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.